Approval · Notice of Compliance 18893 · 2017
ALVESCO: Notice of Compliance 18893
Issued January 20, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18893
- Date
- January 20, 2017
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Transfer of drug identification numbers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALVESCO | Not yet assigned | — |
Medicinal ingredients
- CICLESONIDE 100 MCG per ACT
- CICLESONIDE 200 MCG per ACT